We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Ecolab (ECL) Q3: Wall Street Projections for Key Metrics
Read MoreHide Full Article
In its upcoming report, Ecolab (ECL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.18 per share, reflecting an increase of 5.3% compared to the same period last year. Revenues are forecasted to be $4.67 billion, representing a year-over-year increase of 12.2%.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Ecolab metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Net Sales- Fixed Currency Rates- Global Pest Elimination' will reach $359.87 million. The estimate indicates a change of +11.6% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Fixed Currency Rates- Global Water' of $2.50 billion. The estimate suggests a change of +27.9% year over year.
According to the collective judgment of analysts, 'Net Sales- Fixed Currency Rates- Global Life Sciences' should come in at $211.13 million. The estimate indicates a change of +23.5% from the prior-year quarter.
The average prediction of analysts places 'Net Sales- Fixed Currency Rates- Global Institutional & Specialty' at $1.68 billion. The estimate indicates a year-over-year change of +8.5%.
The consensus among analysts is that 'Net Sales- Public Currency Rates- Global Life Sciences' will reach $211.20 million. The estimate indicates a year-over-year change of +14.4%.
Analysts' assessment points toward 'Net Sales- Public Currency Rates- Global Pest Elimination' reaching $366.55 million. The estimate suggests a change of +10.5% year over year.
It is projected by analysts that the 'Net Sales- Public Currency Rates- Global Institutional & Specialty' will reach $1.67 billion. The estimate suggests a change of +5% year over year.
The combined assessment of analysts suggests that 'Net Sales- Public Currency Rates- Global Water' will likely reach $2.44 billion. The estimate points to a change of +18.6% from the year-ago quarter.
Analysts expect 'Operating Income (loss)- Fixed Currency Rates- Global Life Sciences' to come in at $39.90 million. Compared to the current estimate, the company reported $28.10 million in the same quarter of the previous year.
Analysts forecast 'Operating Income (loss)- Fixed Currency Rates- Global Pest Elimination' to reach $78.45 million. Compared to the current estimate, the company reported $67.40 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Operating Income (loss)- Fixed Currency Rates- Global Institutional & Specialty' should arrive at $417.20 million. Compared to the present estimate, the company reported $365.00 million in the same quarter last year.
The consensus estimate for 'Operating Income (loss)- Fixed Currency Rates- Global Water' stands at $445.66 million. Compared to the present estimate, the company reported $336.00 million in the same quarter last year.
Ecolab shares have witnessed a change of +4.1% in the past month, in contrast to the Zacks S&P 500 composite's no move. With a Zacks Rank #4 (Sell), ECL is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Insights Into Ecolab (ECL) Q3: Wall Street Projections for Key Metrics
In its upcoming report, Ecolab (ECL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.18 per share, reflecting an increase of 5.3% compared to the same period last year. Revenues are forecasted to be $4.67 billion, representing a year-over-year increase of 12.2%.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Ecolab metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts predict that the 'Net Sales- Fixed Currency Rates- Global Pest Elimination' will reach $359.87 million. The estimate indicates a change of +11.6% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Fixed Currency Rates- Global Water' of $2.50 billion. The estimate suggests a change of +27.9% year over year.
According to the collective judgment of analysts, 'Net Sales- Fixed Currency Rates- Global Life Sciences' should come in at $211.13 million. The estimate indicates a change of +23.5% from the prior-year quarter.
The average prediction of analysts places 'Net Sales- Fixed Currency Rates- Global Institutional & Specialty' at $1.68 billion. The estimate indicates a year-over-year change of +8.5%.
The consensus among analysts is that 'Net Sales- Public Currency Rates- Global Life Sciences' will reach $211.20 million. The estimate indicates a year-over-year change of +14.4%.
Analysts' assessment points toward 'Net Sales- Public Currency Rates- Global Pest Elimination' reaching $366.55 million. The estimate suggests a change of +10.5% year over year.
It is projected by analysts that the 'Net Sales- Public Currency Rates- Global Institutional & Specialty' will reach $1.67 billion. The estimate suggests a change of +5% year over year.
The combined assessment of analysts suggests that 'Net Sales- Public Currency Rates- Global Water' will likely reach $2.44 billion. The estimate points to a change of +18.6% from the year-ago quarter.
Analysts expect 'Operating Income (loss)- Fixed Currency Rates- Global Life Sciences' to come in at $39.90 million. Compared to the current estimate, the company reported $28.10 million in the same quarter of the previous year.
Analysts forecast 'Operating Income (loss)- Fixed Currency Rates- Global Pest Elimination' to reach $78.45 million. Compared to the current estimate, the company reported $67.40 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Operating Income (loss)- Fixed Currency Rates- Global Institutional & Specialty' should arrive at $417.20 million. Compared to the present estimate, the company reported $365.00 million in the same quarter last year.
The consensus estimate for 'Operating Income (loss)- Fixed Currency Rates- Global Water' stands at $445.66 million. Compared to the present estimate, the company reported $336.00 million in the same quarter last year.
View all Key Company Metrics for Ecolab here>>>Ecolab shares have witnessed a change of +4.1% in the past month, in contrast to the Zacks S&P 500 composite's no move. With a Zacks Rank #4 (Sell), ECL is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .